Самородская И.В., Андреев Е.М., Заратьянц О.В., Косивцова О.В., Какорина Е.П. Показатели смертности населения старше 50 лет от цереброваскулярных болезней за 15-летний период в России и США. Неврология, нейропсихиатрия, психосоматика. 2017;9(2):15–24. doi: 10.14412/2074-2711-2017-2-15-24..
DOI: 10.14412/2074-2711-2017-2-15-24
Thomalla G., Simonsen C.Z., Boutitie F., Andersen G., Berthezene Y., Cheng B. et al. WAKE-UP Investigators. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med. 2018;379(7):611–622. doi: 10.1056/NEJMoa1804355..
DOI: 10.1056/NEJMoa1804355
Campbell B.C.V., Ma H., Ringleb P.A., Parsons M.W., Churilov L., Bendszus M. et al. Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. Lancet. 2019;394(10193):139–147. doi: 10.1016/S0140-6736(19)31053-0..
DOI: 10.1016/S0140-6736(19)31053-0
Albers G.W., Marks M.P., Kemp S., Christensen S., Tsai J.P., Ortega-Gutierrez S. et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378(8):708–718. doi: 10.1056/NEJMoa1713973..
DOI: 10.1056/NEJMoa1713973
Nogueira R.G., Jadhav A.P., Haussen D.C., Bonafe A., Budzik R.F., Bhuva P. et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378(1):11–21. doi: 10.1056/NEJMoa1706442..
DOI: 10.1056/NEJMoa1706442
Albers G.W. Late Window Paradox. Stroke. 2018;49(3):768–771. doi: 10.1161/STROKEAHA.117.020200..
DOI: 10.1161/STROKEAHA.117.020200
Кулеш А.А., Сыромятникова Л.И., Голосова Ю.А., Шестаков В.В. Опыт проведения тромболитической терапии у больных с острыми нарушениями мозгового кровообращения: эффективность, безопасность, предикторы исхода и геморрагической трансформации. Журнал неврологии и психиатрии им. С.С. Корсакова. 2018;118(7):18–24. doi: 10.17116/jnevro20181187118..
DOI: 10.17116/jnevro20181187118
Lees K.R., Emberson J., Blackwell L., Bluhmki E., Davis S.M., Donnan G.A. et al. Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials. Stroke. 2016;47(9):2373–2379. doi: 10.1161/STROKEAHA.116.013644..
DOI: 10.1161/STROKEAHA.116.013644
Кулеш А.А., Шестаков В.В. Сосудистые недементные когнитивные нарушения: диагноз, прогноз, лечение и профилактика. Неврология, нейропсихиатрия, психосоматика. 2017;9(3):68–75. doi: 10.14412/2074-2711-2017-3-68-75..
DOI: 10.14412/2074-2711-2017-3-68-75
Вербицкая С.В., Парфенов В.А., Решетников В.А., Козлов В.В., Кабаева А.Р. Постинсультные когнитивные нарушения (результаты 5-летнего наблюдения). Неврология, нейропсихиатрия, психосоматика. 2018;10(1):37–42. doi: 10.14412/2074-2711-2018-1-37-42..
DOI: 10.14412/2074-2711-2018-1-37-42
Rha J.H., Saver J.L. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38(3):967–973. doi: 10.1161/01.STR.0000258112.14918.24..
DOI: 10.1161/01.STR.0000258112.14918.24
Soares B.P., Tong E., Hom J., Cheng S.C., Brendo J., Boussel L. et al. Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: a proof of concept using CT in acute ischemic stroke patients. Stroke. 2010;41(1):e34–e40. doi: 10.1161/STROKEAHA.109.568766..
DOI: 10.1161/STROKEAHA.109.568766
Chamorro А. Neuroprotectants in the Era of Reperfusion Therapy. Review. J Stroke. 2018;20(2):197–207. doi: 10.5853/jos.2017.02901..
DOI: 10.5853/jos.2017.02901
Chamorro А., Blasco J., López A., Amaro S., San Roman L., Llull L. et al. Complete reperfusion is required for maximal benefits of mechanical thrombectomy in stroke patients. Sci Rep. 2017;7(1):11636. doi: 10.1038/s41598-017-11946-y..
DOI: 10.1038/s41598-017-11946-y
Hall C.N., Reynell C., Gesslein B., Hamilton N.B., Mishra A., Sutherland B.A. et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 2014;508(7494):55–60. doi: 10.1038/nature13165..
DOI: 10.1038/nature13165
Fisher M., Saver J.L. Future directions of acute ischaemic stroke therapy. Lancet Neurol. 2015;14(7):758–767. doi: 10.1016/S1474-4422(15)00054-X..
DOI: 10.1016/S1474-4422(15)00054-X
Lo E.H., Moskowitz M.A., Jacobs T.P. Exciting, radical, suicidal: how brain cells die after stroke. Stroke. 2005;36(2):189–192. doi: 10.1161/01.STR.0000153069.96296.fd..
DOI: 10.1161/01.STR.0000153069.96296.fd
O’Collins V.E., Macleod M.R., Donnan G.A., Horky L.L., van der Worp B.H., Howells D.W. 1,026 experimental treatments in acute stroke. Ann Neurol. 2006;59(3):467–477. doi: 10.1002/ana.20741..
DOI: 10.1002/ana.20741
Xiong X.Y., Liu L., Yang Q.W. Refocusing Neuroprotection in Cerebral Reperfusion Era: New Challenges and Strategies. Front Neurol. 2018;9:249. doi: 10.3389/fneur.2018.00249..
DOI: 10.3389/fneur.2018.00249
Chamorro А., Dirnagl U., Urra X., Planas A.M. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol. 2016;15(8):869–881. doi: 10.1016/S1474-4422(16)00114-9..
DOI: 10.1016/S1474-4422(16)00114-9
Savitz S.I., Baron J.C., Yenari M.A., Sanossian N., Fisher M. Reconsidering Neuroprotection in the Reperfusion Era. Stroke. 2017;48(12):3413–3419. doi: 10.1161/STROKEAHA.117.017283..
DOI: 10.1161/STROKEAHA.117.017283
Manzanero S., Santro T., Arumugam T.V. Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury. Neurochem Int. 2013;62(5):712–718. doi: 10.1016/j.neuint.2012.11.009..
DOI: 10.1016/j.neuint.2012.11.009
Tsai J.P., Albers G.W. Reperfusion versus recanalization: the winner is. Stroke. 2015;46(6):1433–434. doi: 10.1161/STROKEAHA.115.009268..
DOI: 10.1161/STROKEAHA.115.009268
Rothman S.M., Olney J.W. Glutamate and the pathophysiology of hypoxic–ischemic brain damage. Ann Neurol. 1986;19(2):105–111. doi: 10.1002/ana.410190202..
DOI: 10.1002/ana.410190202
Saver J.L., Starkman S., Eckstein M., Stratton S.J., Pratt F.D., Hamilton S. et al. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med. 2015;372(6):528–536. doi: 10.1056/NEJMoa1408827..
DOI: 10.1056/NEJMoa1408827
Fukuyama N., Takizawa S., Ishida H., Hoshiai K., Shinohara Y., Nakazawa H. Peroxynitrite formation in focal cerebral ischemia-reperfusion in rats occurs predominantly in the peri-infarct region. J Cereb Blood Flow Metab. 1998;18(2):123–129. doi: 10.1097/00004647-199802000-00001..
DOI: 10.1097/00004647-199802000-00001
Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87(1):315–424. doi: 10.1152/physrev.00029.2006..
DOI: 10.1152/physrev.00029.2006
Shuaib A., Lees K.R., Lyden P., Grotta J., Davalos A., Davis S.M. et al. NXY- 059 for the treatment of acute ischemic stroke. N Engl J Med. 2007;357(6):562–571. doi: 10.1056/NEJMoa070240..
DOI: 10.1056/NEJMoa070240
Onetti Y., Dantas A.P., Pérez B., Cugota R., Chamorro A., Planas A.M. et al. Middle cerebral artery remodeling following transient brain ischemia is linked to early postischemic hyperemia: a target of uric acid treatment. Am J Physiol Heart Circ Physiol. 2015;308(8):H862–H874. doi: 10.1152/ajpheart.00001.2015..
DOI: 10.1152/ajpheart.00001.2015
Llull L., Laredo C., Renú A., Perez B., Vila E., Obach V. et al. Uric acid therapy improves clinical outcome in women with acute ischemic stroke. Stroke. 2015;46(8):2162–2167. doi: 10.1161/STROKEAHA.115.009960..
DOI: 10.1161/STROKEAHA.115.009960
Amaro S., Llull L., Renú A., Laredo C., Perez B., Vila E. et al. Uric acid improves glucose-driven oxidative stress in human ischemic stroke. Ann Neurol. 2015;77(5):775–783. doi: 10.1002/ana.24378..
DOI: 10.1002/ana.24378
Feng S., Yang Q., Liu M., Li W., Yuan W., Zhang S. et al. Edaravone for acute ischemic stroke. Cochrane Database Syst Rev. 2011;(12):CD007230. doi: 10.1002/14651858.CD007230.pub2..
DOI: 10.1002/14651858.CD007230.pub2
Miyaji Y., Yoshimura S., Sakai N., Yamagami H., Egashira Y., Shirakawa M. et al. Effect of edaravone on favorable outcome in patients with acute cerebral large vessel occlusion: subanalysis of RESCUE-Japan Registry. Neurol Med Chir (Tokyo). 2015;55(3):241–247. doi: 10.2176/nmc.ra.2014-0219..
DOI: 10.2176/nmc.ra.2014-0219
Enomoto M., Endo A., Yatsushige H., Fushimi K., Otomo Y. Clinical Effects of Early Edaravone Use in Acute Ischemic Stroke Patients Treated by Endovascular Reperfusion Therapy. Stroke. 2019;50(3):652–658. doi: 10.1161/STROKEAHA.118.023815..
DOI: 10.1161/STROKEAHA.118.023815
Kobayashi S., Fukuma S., Ikenoue T., Fukuhara S., Kobayashi S. Effect of Edaravone on Neurological Symptoms in Real-World Patients With Acute Ischemic Stroke. Stroke. 2019;50(7):1805–1811. doi: 10.1161/STROKEAHA.118.024351..
DOI: 10.1161/STROKEAHA.118.024351
Ejaz S., Emmrich J.V., Sitnikov S.L., Hong Y.T., Sawiak S.J., Fryer T.D. et al. Normobaric hyperoxia markedly reduces brain damage and sensorimotor deficits following brief focal ischaemia. Brain. 2016;139(3):751–764. doi: 10.1093/brain/awv391..
DOI: 10.1093/brain/awv391
Padma M.V., Bhasin A., Bhatia R., Garg A., Singh M.B., Tripathi M., Prasad K. Normobaric oxygen therapy in acute ischemic stroke: a pilot study in Indian patients. Ann Indian Acad Neurol. 2010;13(4):284–288. doi: 0.4103/0972-2327.74203..
DOI: 0.4103/0972-2327.74203
Singhal A.B., Benner T., Roccatagliata L., Koroshetz W.J., Schaefer P.W., Lo E.H. et al. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke. 2005;36(4):797–802. doi: 10.1161/01.STR.0000158914.66827.2e..
DOI: 10.1161/01.STR.0000158914.66827.2e
Landman T.R.J., Schoon Y., Warlé M.C., de Leeuw F-E., Thijssen D.H.J. Remote Ischemic Conditioning as an Additional Treatment for Acute Ischemic Stroke. Stroke. 2019;50(7):1934–1939. doi: 10.1161/STROKEAHA.119.025494..
DOI: 10.1161/STROKEAHA.119.025494
Hess D.C., Blauenfeldt R.A., Andersen G., Hougaard K.D., Hoda M.N., Ding Y., Ji X. Remote ischaemic conditioning-a new paradigm of self-protection in the brain. Nat Rev Neurol. 2015;11(12):698–710. doi: 10.1038/nrneurol.2015.223..
DOI: 10.1038/nrneurol.2015.223
Hougaard K.D., Hjort N., Zeidler D., Sørensen L., Nørgaard A., Hansen T.M. et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke. 2014;45(1):159–167. doi: 10.1161/STROKEAHA.113.001346..
DOI: 10.1161/STROKEAHA.113.001346
England T.J., Hedstrom A., O’Sullivan S., Donnelly R., Barrett D.A., Sarmad S. et al. RECAST (Remote Ischemic Conditioning After Stroke Trial): a pilot randomized placebo controlled phase II trial in acute ischemic stroke. Stroke. 2017;48(5):1412–1415. doi: 0.1161/STROKEAHA.116.016429..
DOI: 0.1161/STROKEAHA.116.016429
Meng R., Asmaro K., Meng L., Liu Y., Ma C., Xi C. et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology. 2012;79(18):1853–1861. doi: 10.1212/WNL.0b013e318271f76a..
DOI: 10.1212/WNL.0b013e318271f76a
Meng R., Ding Y., Asmaro K., Brogan D., Meng L., Sui M. et al. Ischemic conditioning is safe and effective for octo- and nonagenarians in stroke prevention and treatment. Neurotherapeutics. 2015;12:667–677. doi: 10.1007/s13311-015-0358-6..
DOI: 10.1007/s13311-015-0358-6
Кулеш А.А., Дробаха В.Е., Шестаков В.В. Церебральная болезнь мелких сосудов: классификация, клинические проявления, диагностика и особенности лечения. Неврология, нейропсихиатрия, психосоматика. 2019;11(3S):4–17. doi: 10.14412/2074-2711-2019-3S-4-17..
DOI: 10.14412/2074-2711-2019-3S-4-17
Mi T., Yu F., Ji X., Sun Y., Qu D. The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. Eur Neurol. 2016;76(1–2):28–34. doi: 10.1159/000447536..
DOI: 10.1159/000447536
Wang Y., Meng R., Song H., Liu G., Hua Y., Cui D. et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small-vessel disease. Stroke. 2017;48(11):3064–3072. doi: 0.1161/STROKEAHA.117.017691..
DOI: 0.1161/STROKEAHA.117.017691
Zhao W., Zhang J., Sadowsky M.G., Meng R., Ding Y., Ji X. Remote ischaemic conditioning for preventing and treating ischaemic stroke. Cochrane Database Syst Rev. 2018;7(7):CD012503. doi: 10.1002/14651858.CD012503.pub2..
DOI: 10.1002/14651858.CD012503.pub2
Pico F., Rosso C., Meseguer E., Chadenat M-L., Cattenoy A., Aegerter P. et al. A multicenter, randomized trial on neuroprotection with remote ischemic per-conditioning during acute ischemic stroke: the REmote iSchemic Conditioning in acUtE BRAin INfarction study protocol. Int J Stroke. 2016;11(8):938–943. doi: 10.1177/1747493016660098..
DOI: 10.1177/1747493016660098
Kurisu K., Yenari M.A. Therapeutic hypothermia for ischemic stroke; pathophysiology and future promise. Review. Neuropharmacology. 2018;134(B):302–309. doi: 10.1016/j.neuropharm.2017.08.025..
DOI: 10.1016/j.neuropharm.2017.08.025
Lyden P.D., Allgren R.L., Ng K., Akins P., Meyer B., Al-Sanani F. et al. Intravascular Cooling in the Treatment of Stroke (ICTuS): early clinical experience. J Stroke Cerebrovasc Dis. 2005;14(3):107–114. doi: 10.1016/j.jstrokecerebrovasdis.2005.01.001..
DOI: 10.1016/j.jstrokecerebrovasdis.2005.01.001
Hemmen T.M., Raman R., Guluma K.Z., Meyer B.C., Gomes J.A., Cruz-Flores S. et al. Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final result Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2). Therapeutic hypothermia for ischemic stroke; pathophysiology and future promise. Stroke. 2010;41(10):2265–2270. doi: 10.1161/STROKEAHA.110.592295..
DOI: 10.1161/STROKEAHA.110.592295
Bornstein N.M., Saver J.L., Diener H.C., Gorelick P.B., Shuaib A., Solberg Y. et al. Sphenopalatine Ganglion Stimulation to Augment Cerebral Blood Flow. Stroke. 2019;STROKEAHA118024582. doi: 10.1161/STROKEAHA.118.024582..
DOI: 10.1161/STROKEAHA.118.024582
Bornstein N.M., Saver J.L., Diener H.C., Gorelick P.B., Shuaib A., Solberg Y. et al. An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT 24B): an international, randomised, double-blind, sham controlled, pivotal trial. Lancet. 2019;394(10194):219–229. doi: 10.1016/S0140-6736(19)31192-4..
DOI: 10.1016/S0140-6736(19)31192-4
Gutiérrez-Fernández M., Rodríguez-Frutos B., Fuentes B., Vallejo-Cremades M.T., Alvares-Grech J., Expósito-Alcaide M., Díez-Tejedorab E. CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke. Neurochem Int. 2012;60(3):310–317. doi: 10.1016/j.neuint.2011.12.015..
DOI: 10.1016/j.neuint.2011.12.015
Alvarez-Sabín J., Román G.C. The role of citicoline in neuroprotection and neurorepair in ischemic stroke. Brain Sci. 2013;3(3):1395–1414. doi: 10.3390/brainsci3031395..
DOI: 10.3390/brainsci3031395
Hurtado O., Cárdenas A., Pradillo, J.M., Morales J.R., Ortego F., Sobrino T. et al. A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimiental stroke. Neurobiol Dis. 2007;26(1):105–111. doi: 10.1016/j.nbd.2006.12.005..
DOI: 10.1016/j.nbd.2006.12.005
Hurtado O., Lizasoain I., Moro M.Á. Neuroprotection and recovery: recent data at the bench on citicoline. Stroke. 2011;42(1):33–35. doi: 10.1161/STROKEAHA.110.597435..
DOI: 10.1161/STROKEAHA.110.597435
Sobrino T., Rodríguez-González R., Blanco M., Brea D., Perez-Mato M., Rodríguez-Yáñez M. et al. CDP-choline treatment increases circulating endotelial progenitor cells in acute ischemic stroke. Neurol Res. 2011;33(6):572–577. doi: 10.1179/016164110X12807570510176..
DOI: 10.1179/016164110X12807570510176
Diederich K., Frauenknecht K., Minnerup J., Schneider B.K., Schmidt A., Altach E. et al. Citicoline enhances neuroregenerative processes after experimental stroke in rats. Stroke. 2012;43(7):1931–1940. doi: 10.1161/STROKEAHA.112.654806..
DOI: 10.1161/STROKEAHA.112.654806
Kuprinski J., Abudawood M., Matou-Nasri S., Al-Baradie R., Petcu E.B., Justicia C. et al. Citicoline induces angiogenesis improving survival of vascular/human brain microvessel endothelial cells through pathways involving ERK1/2 and insulin receptor substrate-1. Vasc Cell. 2012;4(1):20. doi: 10.1186/2045-824X-4-20..
DOI: 10.1186/2045-824X-4-20
Bramanti V., Campisi A., Tomassoni D., Li Volti G., Caccamo D., Gannavó G. et al. Effect of acetylcholine precursors on proliferation and differentiation of astroglial cells in primary cultures. Neurochem Res. 2008;33(12):2601–2608. doi: 10.1007/s11064-008-9829-z..
DOI: 10.1007/s11064-008-9829-z
Clark W., Warach S., Pettigrew L., Gammans R.E., Sabounjian L.A. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Neurology. 1997;49(3):671–678. doi: 10.1212/wnl.49.3.671..
DOI: 10.1212/wnl.49.3.671
Clark W., Wechsler L., Sabounjian L., Schwiderski U. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology. 2001;57(9):1595–1602. doi: 10.1212/wnl.57.9.1595..
DOI: 10.1212/wnl.57.9.1595
Clark W., Williams B., Selzer K., Zweifler R.M., Sabounjian L.A., Gammans R.E. A Randomized Efficacy Trial of Citicoline in Patients With Acute Ischemic Stroke. Stroke. 1999;30(12):2592–2597. doi: 10.1161/01.str.30.12.2592..
DOI: 10.1161/01.str.30.12.2592
Dávalos A., Castillo J., Alvarez-Sabín J., Secades J.J., Mercadal J., López S. et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke. 2002;33(12):2850–2857. doi: 10.1161/01.str.0000038691.03334.71..
DOI: 10.1161/01.str.0000038691.03334.71
Saver J.L. Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair. Rev Neurol Dis. 2008;5(4):167–177. Available at: https://www.ncbi.nlm.nih.gov/pubmed/19122569.https://www.ncbi.nlm.nih.gov/pubmed/19122569
Saver J.L. Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair. Rev Neurol Dis. 2008;5(4):167–177. Available at: https://www.ncbi.nlm.nih.gov/pubmed/19122569.https://www.ncbi.nlm.nih.gov/pubmed/19122569
Dávalos A., Alvarez-Sabín J., Castillo J., Diez-Tejedor E., Ferro J., Martínez-Vila E. et al. International Citicoline Trial on acUte Stroke (ICTUS) trial investigators. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet. 2012;380(9839):349–357. doi: 10.1016/S0140-6736(12)60813-7..
DOI: 10.1016/S0140-6736(12)60813-7
Сергеев Д.В., Домашенко М.А., Пирадов М.А. Фармакологическая нейропротекция при ишемическом инсульте в реальных клинических условиях. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017;117(4):86–91. doi: 10.17116/jnevro20171174186-91..
DOI: 10.17116/jnevro20171174186-91
Secades J.J., Alvarez-Sabín J., Castillo J., Diez-Tejedor E., Martinez-Vila E., Rios J., Oudovenko N. Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials. J Stroke Cerebrovasc Dis. 2016;25(8):1984–1996. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.010..
DOI: 10.1016/j.jstrokecerebrovasdis.2016.04.010
Скворцова В.И., Шетова И.М., Какорина Е.П., Камкин Е.Г., Бойко Е.Л., Дашьян В.Г., Крылов В.В. Организация помощи пациентам с инсультом в России. Итоги 10 лет реализации Комплекса мероприятий по совершенствованию медицинской помощи пациентам с острыми нарушениями мозгового кровообращения. Анналы клинической и экспериментальной неврологии. 2018;12(3):5–12. doi: 10.25692/ACEN.2018.3.1..
DOI: 10.25692/ACEN.2018.3.1
Скворцова В.И., Шетова И.М., Какорина Е.П., Камкин Е.Г., Бойко Е.Л., Дашьян В.Г., Крылов В.В. Организация помощи пациентам с инсультом в России. Итоги 10 лет реализации Комплекса мероприятий по совершенствованию медицинской помощи пациентам с острыми нарушениями мозгового кровообращения. Анналы клинической и экспериментальной неврологии. 2018;12(3):5–12. doi: 10.25692/ACEN.2018.3.1..
DOI: h10.25692/ACEN.2018.3.1
Alvarez-Sabín J., Santamarina E., Maisterra O., Jacas C., Molina C., Quintana M. Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke. Int J Mol Sci. 2016;17(3):390. doi: 10.3390/ijms17030390..
DOI: 10.3390/ijms17030390